Your browser doesn't support javascript.
loading
Template-assisted covalent modification underlies activity of covalent molecular glues.
Li, Yen-Der; Ma, Michelle W; Hassan, Muhammad Murtaza; Hunkeler, Moritz; Teng, Mingxing; Puvar, Kedar; Rutter, Justine C; Lumpkin, Ryan J; Sandoval, Brittany; Jin, Cyrus Y; Schmoker, Anna M; Ficarro, Scott B; Cheong, Hakyung; Metivier, Rebecca J; Wang, Michelle Y; Xu, Shawn; Byun, Woong Sub; Groendyke, Brian J; You, Inchul; Sigua, Logan H; Tavares, Isidoro; Zou, Charles; Tsai, Jonathan M; Park, Paul M C; Yoon, Hojong; Majewski, Felix C; Sperling, Haniya T; Marto, Jarrod A; Qi, Jun; Nowak, Radoslaw P; Donovan, Katherine A; Slabicki, Mikolaj; Gray, Nathanael S; Fischer, Eric S; Ebert, Benjamin L.
Affiliation
  • Li YD; Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA.
  • Ma MW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hassan MM; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Hunkeler M; Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA.
  • Teng M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Puvar K; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Rutter JC; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA.
  • Lumpkin RJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sandoval B; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Jin CY; Center for Drug Discovery, Department of Pathology & Immunology, and Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX, USA.
  • Schmoker AM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ficarro SB; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Cheong H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Metivier RJ; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Wang MY; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Xu S; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Byun WS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Groendyke BJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • You I; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Sigua LH; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Tavares I; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Zou C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Tsai JM; Blais Proteomics Center and Center for Emergent Drug Targets, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Park PMC; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Yoon H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Majewski FC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sperling HT; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Marto JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Qi J; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA.
  • Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Donovan KA; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA.
  • Slabicki M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Fischer ES; Blais Proteomics Center and Center for Emergent Drug Targets, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nat Chem Biol ; 2024 Jul 29.
Article in En | MEDLINE | ID: mdl-39075252
ABSTRACT
Molecular glues are proximity-inducing small molecules that have emerged as an attractive therapeutic approach. However, developing molecular glues remains challenging, requiring innovative mechanistic strategies to stabilize neoprotein interfaces and expedite discovery. Here we unveil a trans-labeling covalent molecular glue mechanism, termed 'template-assisted covalent modification'. We identified a new series of BRD4 molecular glue degraders that recruit CUL4DCAF16 ligase to the second bromodomain of BRD4 (BRD4BD2). Through comprehensive biochemical, structural and mutagenesis analyses, we elucidated how pre-existing structural complementarity between DCAF16 and BRD4BD2 serves as a template to optimally orient the degrader for covalent modification of DCAF16Cys58. This process stabilizes the formation of BRD4-degrader-DCAF16 ternary complex and facilitates BRD4 degradation. Supporting generalizability, we found that a subset of degraders also induces GAK-BRD4BD2 interaction through trans-labeling of GAK. Together, our work establishes 'template-assisted covalent modification' as a mechanism for covalent molecular glues, which opens a new path to proximity-driven pharmacology.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Chem Biol Journal subject: BIOLOGIA / QUIMICA Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Chem Biol Journal subject: BIOLOGIA / QUIMICA Year: 2024 Document type: Article Affiliation country: Country of publication: